Jonathan E Freeman insider trades

Open-market stock purchases and sales by Jonathan E Freeman, Director at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Jun 6, 2017.

Recent trades

DateStockTradeValue
Feb 5, 2026PHIO Phio Pharmaceuticals CorpBought (not open market)—

Companies traded

  • PHIO Phio Pharmaceuticals Corp: other filings, last Feb 5, 2026
  • RXII RXi Pharmaceuticals Corp: other filings, last Aug 1, 2018

Get free alerts when Jonathan E Freeman files a new trade →